Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study documents now show revision v3.6.4, replacing the previous v3.6.3. This indicates an updated version of the protocol/SAP materials in the study package.SummaryDifference0.1%

- Check19 days agoChange DetectedNew Study Record Dates have been added to reflect the latest update (2026-07-17) and an estimated completion (2027-03), along with other recent submission timestamps (2026-06-18, 2026-06). Older dates (2025-10-29, 2026-03, 2025-10-15, 2025-07) have been removed, updating the record history.SummaryDifference0.3%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new document revision tag v3.6.3 has been added. The previous revision v3.6.0 has been removed, indicating an administrative update to the study materials.SummaryDifference0.1%

- Check55 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', affecting who can join or monitor the trial. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision note updated to v3.6.0, with the 'Intervention / Treatment' formatting and the older 'Revision: v3.5.5' note removed.SummaryDifference0.4%

- Check62 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This indicates a new version of the document rather than substantive content changes.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now shows an updated study protocol revision: v3.5.4, replacing the previous revision v3.5.3. This reflects an updated version of the study-related documents linked to the trial.SummaryDifference0.1%

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.